參考文獻 |
Chapter 1
E. W. Toor, D. F. Evans, and E. L. Cussler, “Cholesterol monohydrate growth in model bile solutions,” Proc. Natl. Acad. Sci., 75(12), 6230-6234 (1978).
D. L. Gantz, D. Q.-H. Wang, M. C. Carey, and D. M. Small, “Cryoelectron microscopy of a nucleating model bile in vitreous ice: formation of primordial vesicles,” Biophys. J., 76(3), 1436-1451 (1999).
N. R. Pattinson, “Solubilisation of cholesterol in human bile,” FEBS., 181(2), 339-342 (1985).
G. J. Somjen, and T. Gilat, “Contribution of vesicular and micellar carriers to cholesterol transport in human bile,” J. Lipid Res., 26(6), 699-704 (1985).
M. C. Carey, and D. M. Small, “The physical chemistry of cholesterol solubility in bile,” J. Clin. Invest., 61(4), 998-1026 (1978).
W. H. Admirand, and D. M. Small, “The physicochemical basis of cholesterol gallstone formation in man,” J. Clin. Invest., 47(5), 1043-1052 (1968).
N. Ulloa, J. Garrido, and F. Nervi, “Ultracentrifugal isolation of vesicular carriers of biliary cholesterol in native human and rat bile,” Hepatology, 7(2), 235-244 (1987).
P. Portincasa, A. Moschetta, K. J. van Erpecum, G. Calamita, A. Margari, G. P. van Berge-Henegouwen, and G. Palasciano, “Pathways of cholesterol crystallization in model bile and native bile,” Digestive and Liver Disease, 35(2), 118-126 (2003).
M. C. Carey, “Pathogenesis of gallstones,” Am. J. Surg., 165(4), 410-419 (1993).
H. Igimi, M. C. Carey, “Cholesterol gallstone dissolution in bile: dissolution kinetics of crystalline (anhydrate and monohydrate) cholesterol with chenodeoxycholate, ursodeoxycholate, and their glycine and taurine conjugates,” J. Lipid Res., 22(2) 254-270 (1981).
F. M. Konikoff, D. S. Chung, J. M. Donovan, D. M. Small, and M. C. Carey, “Filamentous, helical, and tubular microstructures during cholesterol crystallization from bile – evidence that cholesterol does not nucleate classic monohydrate plates,” J. Clin. Invest., 90(3), 1155-1160 (1992).
D. E. Cohen, M. Angelico, and M. C. Carey,” Structural alterations in lecithin-cholesterol vesicles following interactions with monomeric and micellar bile salts: physical-chemical basis for subselection of biliary lecithin species and aggregative states of biliary lipids during bile formation,” J. Lipid Res., 31(1), 55-70 (1990).
J. M. Donovan, N. Timofeyeva, and M. C. Carey, “Influence of total lipid concentration, bile salt:lecithin ratio, and cholesterol content on inter-mixed micellar/vesicular (non-lecithin- associated) bile salt concentrations in model bile,” J. Lipid Res., 32(9), 1501-1512 (1991).
D. Q. Wang, and M. C. Carey, “Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems,” J. Lipid Res., 37(3), 606-630 (1996).
R. D. Stauffer, and F. Bischoff, “Solubility determination of cholesterol polymorphs in organic solvents,” Clin. Chem., 12(4), 206-210 (1966).
H. S. Shieh, L. G. Hoard, and C. E. Nordman, “Crystal structure of anhydrous cholesterol,” Nature, 267(5608), 287-289 (1977).
B. M. Craven, “Crystal structure of cholesterol monohydrate,” Nature, 260(5553), 727-729 (1976).
C. R. Loomis, G. G. Shipley, and D. M. Small, “The phase behavior of hydrated cholesterol,” J. Lipid Res., 20(4), 525-535 (1979).
H. Y. Saad, and W .I. Higuchi, “Water solubility of cholesterol,” J. Pharm. Sci., 54(8), 1205-1206 (1965).
G. L. Flynn, Y. Shah, S. Prakongpan, K. H. Kwan, W. I. Higuchi, and A. F. Hofmann, “Cholesterol solubility in organic solvents,” J. Pharm. Sci., 68(9), 1090-1097 (1979).
N. Garti, L. Karpuj, and S. Sarig, “Correlation between crystal habit and the composition of solvated and nonsolvated cholesterol crystals,” J. Lipid Res., 22(5), 785-791 (1981).
N. R. Pattinson, “Solubilisation of cholesterol in human bile,” Feder. Eur. Biochem. Soc., 181(2), 339-342 (1985).
R. T. Holzbach, and N. Busch, “Nucleation and growth of cholesterol crystals – kinetic determinants in supersaturated native bile,” Gastroenterology Clinics of North America, 20(1), 67-84 (1991).
D. Jungst, R. Del Pozo, M. H. Dolu, S. G. Schneeweiss, and E. Frimberger, “Rapid formation of cholesterol crystals in gallbladder bile is associated with stone recurrence after laparoscopic cholecystotomy,” Hepatology, 25(3), 509-513 (1997).
C. L. Liu, and C. F. Hsu, “Cholesterol monohydrates dissolution in bile salt-lecithin solutions,” J. Chin. Chem. Soc., 47(3), 461-467 (2000).
T. Nishioka, S. Tazuma, G. Yamashita, and G. Kajiyama, “Partial replacement of bile salts causes marked changes of cholesterol crystallization in supersaturated model bile systems,” Biochem. J., 340(2), 445-451 (1999).
H. Rapaport, I. Kuzmenko, S Lafont, K. Kjaer, P. B. Howes, J. Als-Nielsen, M. Lahav, and L. Leiserowitz, “Cholesterol monohydrate nucleation in ultrathin films on water,” Biophys. J., 81(5), 2729-2736 (2001).
R. S. Abendan, and J. A. Swift, “Surface characterization of cholesterol monohydrate single crystals by chemical force microscopy,” Langmuir, 18(12), 4847-4853 (2002).
R. C. Srivastava, and R. P. S. Jakhar, “Transport through liquid membranes generated by lecithin-cholesterol mixtures,” J. Phys. Chem., 86(5), 1441-1445 (1982).
R. M. Epand, R. F. Epand, D. W. Hughes, B. G. Sayer, N. Borochov, D. Bach, and E. Wachtel, “Phosphatidylcholine structure determines cholesterol solubility and lipid polymorphism,” Chem. Phys. Lipids., 135(1), 39-53 (2005).
D. E. Cohen, M. Angelico, and M. C. Carey, “Structural alterations in lecithin-cholesterol vesicles following interactions with monomeric and micellar bile salts: physical-chemical basis for subselection of biliary lecithin species and aggregative states of biliary lipids during bile formation,” J. Lipid Res., 31(1), 55-70 (1990).
H. Igimi, M. C. Carey, “Cholesterol gallstone dissolution in bile: dissolution kinetics of crystalline (anhydrate and monohydrate) cholesterol with chenodeoxycholate, ursodeoxycholate, and their glycine and taurine conjugates,” J. Lipid Res., 22(2) 254-270 (1981).
F. M. Konikoff, D. S. Chung, J. M. Donovan, D. M. Small, and M. C. Carey, “Filamentous, helical, and tubular microstructures during cholesterol crystallization from bile – evidence that cholesterol does not nucleate classic monohydrate plates,” J. Clin. Invest., 90(3), 1155-1160 (1992).
D. E. Cohen, M. Angelico, and M. C. Carey,” Structural alterations in lecithin-cholesterol vesicles following interactions with monomeric and micellar bile salts: physical-chemical basis for subselection of biliary lecithin species and aggregative states of biliary lipids during bile formation,” J. Lipid Res., 31(1), 55-70 (1990).
J. M. Donovan, N. Timofeyeva, and M. C. Carey, “Influence of total lipid concentration, bile salt:lecithin ratio, and cholesterol content on inter-mixed micellar/vesicular (non-lecithin- associated) bile salt concentrations in model bile,” J. Lipid Res., 32(9), 1501-1512 (1991).
D. Q. Wang, and M. C. Carey, “Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems,” J. Lipid Res., 37(3), 606-630 (1996).
W. J. Claffey, and R. T. Holzbach, “Dimorphism in bile salt/lecithin mixed micelles,” Biochemistry, 20(2), 415-418 (1981).
N. Rajagopalan, and S. Lindenbaum, “Kinetics and thermodynamics of the formation of mixed micelles of egg phosphatidylcholine and bile salts,” J. Lipid Res., 25(2), 135-147 (1984).
N. A. Mazer, G. B. Benedek, and M. C. Carey, “Quasielastic light-scattering studies of aqueous biliary lipid systems. mixed micelle formation in bile salt-lecithin solution,” Biochemistry, 19(4), 601-615 (1980).
D. Meyuhas, A. Bor, I. Pinchuk, A. Kaplun, Y. Talmon, M. M. Kozlov, and D. Lichtenberg, “Effect of ionic strength on the self-assembly in mixtures of phosphatidylcholine and sodium cholate,” J. Colloid Inter. Sci., 188(2), 351-362 (1997).
D. D. Lasic, “Kinetic and thermodynamic effects on the structure and formation of phosphatidylcholine vesicles,” Hepatology, 13(5), 1010-1012 (1991).
P. K. Vinson, Y. Talmon, and A. Walter, “Vesicle-micelle transition of phosphatidylcholine and octyl glucoside elucidated by cryo-transmission electron microscopy,” Biophys. J., 56(4), 669-681 (1989).
Y. Li, J. F. Holzwarth, and C. Bohne, “Aggregation dynamics of sodium taurodeoxycholate and sodium deoxycholate,” Langmuir, 16(4), 2038-2041 (2000).
E. Bottari, A. A. D’Archivio, M. R. Festa, L. Galantini, and E. Giglio, “Structure composition of sodium taurocholate micellar aggregates,” Langmuir, 15(8), 2996-2998 (1999).
R. Holzbach, “ Nucleation of cholesterol crystals in native bile,” Hepatology 12(3 Pt 2), 155-159 (1990).
D. R. Taylor, R. S. Crowther, J. C. Cozart, P. Sharrock, J. Wu, and R. D. Soloway, “Calcium carbonate in cholesterol gallstones: polymorphism, distribution, and hypotheses about pathogenesis,” Hapatology, 22(2), 488-496 (1995).
P. Portincasa, A. Moschetta, and G. Palasciano, “Cholesterol gallstone disease,” Seminar, 368(9531), 230-239 (2006).
...........................................................
Chapter 2
D. J. W. Grant, “Theory and origin of polymorphism,” Chapter 1 in “Polymorphism in pharmaceutical solids,” edited by H. G. Brittain, (Marcel Dekker, Inc., New York, 1999) pp. 1-21.
J. Haleblian, and W. McCrone, “Pharmaceutical applications of polymorphism,” J. Pharm. Sci., 58(8), 911-929 (2006).
A. K. Tiwary, “Modification of crystal habit and its role in dosage form performance,” Drug. Dev. Ind. Pharm. 27(7): 699-709 (2001).
T. L. Threlfall, “Analysis of organic polymorphs: a review,” Analyst, 120(10), 2435-2460 (1995).
V. Koradia, G. Chawla, and A. K. Bansal, “Qualitive and quantitative analysis of clopidogrel bisulphate polymorphs,” Acta Pharm. 54(3), 193-204 (2004).
G. Chawala, and A. K. Bansal, “Challenges in polymorphism of pharmaceuticals,” CRIPS 5(1), 9-12 (2004).
G. Nichols, and C. S. Frampton, “Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution,” J. Pharm. Sci., 87(6), 684-693 (1998).
L. Yu, S. M. Reutzel, and G. A. Stephenson, “Physical characterization of polymorphic drugs: an integrated characterization strategy,” PSTT, 1(3), 118-127 (1998).
M. Cölle, J. Gmeiner, W. Milius, H. Hillebrecht, W. Brütting, “Preparation and Characterization of Blue-Luminescent Tris(8-hydroxyquinoline)-aluminum (Alq3),” Adv. Funct. Mater., 13(2), 108-112 (2003).
D. L. Pavia, G. M. Lampman, G. S. Kriz, “Introduction to spectroscopy,” Chapter 2 in “Infrared Spectroscopy,” 3nd Edition, (Brooks/COLE Thomson Learning, USA, 2001) pp.13-24.
K. Gotoh, H. Masuda, and K. Higashitani, “Optical Properties,” Chapter 2 in “Powder technology handbook,” 2nd Edition, (Marcel Dekker, Inc, New York, 1997) pp. 92.
J. E. Macur, J. Marti, and S. C. Lui, “Microscopy,” Chapter 8 in “Matericals characterization and chemical analysis,” 2nd Edition, (J. P. Sibilia, Wiley-Vch, New York, USA, 1996) pp. 167-177.
K. Gotoh, H. Masuda, and K. Higashitani, “Powder-handling operation,” Chapter 5 in “Powder technology handbook,” 2nd Edition, (Marcel Dekker, Inc, New York, 1997) pp. 413-730.
D. A. Skoog, F. J. Holler and T. A. Nieman, “Surface Characterization by Spectroscopy and Microscopy,” Chapter 21 in “Principles of instrumental analysis,” 5nd Edition, (Thomson Learning, USA, 2001), pp. 549-553.
R. E. Reed-hill, “Analytical Methods,” Chapter 2 in “Physical Metallurgy Principles,” 3nd Edition, edited by J. Plant, (PWS Publishing Company, Boston, USA, 1994), pp.53-60.
S. D. Russell and C. P. Daghlian, “Scanning electron microscopic observations on deembedded biological tissue sections: Comparison of different fixatives and embedding materials,” J. Electron. Microsc. Tech., 2(5), 489-495 (1985).
W. E. Lee, and K. P. D. Lagrelof, “Structural and electron diffraction data for sapphire (α-Al2O3),” J. Electron Microsc., 2(3), 247-258 (1985).
E. V. Boldyerva, V. A. Drebushchak, I. E. Paukov, Y. A. Kovalevskaya, and T. N. Drebushchak, “DSC and adiabatic calorimetry study of the polymorphs of paracetamol,” J. of Them. Anal. Calor., 77(2), 607-623 (2004).
S. D. Clas, C. R. Dalton and B. C. Hancock, “Differential scanning calorimetry: applications in drug development,” PSTT 2(8), 311-320 (1999).
D. A. Skoog, F. J. Holler and T. A. Nieman, “Thermal Methods,” Chapter 31 in “Principles of instrumental analysis,” 5th Edition, (Thomson Learning, USA, 2001), pp. 798-801.
F. Rouessac, and A. Rouessac, “Chemical Analysis-modern Instrumentation Methods and Techniques,” Chapter 10 in “Infrared spectroscopy,” 1st Edition, (John Willy & Sons, chichester, England, 2001), pp.170-173.
D. A. Skoog, F. J. Holler, and T. A. Nieman, “Components of Optical Instrument,” Chapter 7 in “Principles of Instrumental Analysis,” 5th Edition, (Thomson Learning, Mississippi, USA, 2001), pp. 182-183.
A. Bauer-Brandl, “Polymorphic Transitions of Cimetidine during Manufacture of Solid Dosage Forms,” Int. J. Pharm., 140(2), 195-206 (1996).
N. S. Murthy, and F. Reidinger, “X-ray analysis,” Chapter 7 in “Matericals characterization and chemical analysis,” J. P. Sibilia, (Wiley-Vch , New York, USA, 1996) pp. 143-149.
M. Davidovich, J. Dimarco, J. Z. Gougoutas, R. P. Scaringe, I. Vitez, S. Yin, “Detection of polymorphic artifacts in powder x-ray diffraction determination,” Am. Pharm. Rev., 138 (1), 1-2 (1996).
..........................................................
Chapter 3
T. Togkalidou, R. D. Braatz, B. K. Johnson, O. Davidson, and A. Andrews, “Experimental Design and Inferential Modeling in Pharmaceutical Crystallization,” AIChE Journal, 47(1), 160-168 (2001).
T. Lee, C. S. Kuo, and Y. H. Chen, “Solubility, Polymorphism, Crystallinity, and Crystal Habit of Acetaminophen and Ibuprofen by Initial Solvent Screening,” Pharm. Tech., 30(10), 72-92 (2006).
R. Holzbach, “Nucleation of cholesterol crystals in native bile,” Hepatology 12(3 Pt 2), 155-159 (1990).
H. G. Brittain, and D. J. W. Grant, Chapter 7:“Effect of Polymorphism” “Polymorphism in Pharmaceutical Solids.” Edited by H. G. Brttain, (Marcel Dekker, New York, 1999) pp. 279-330.
C. Reichardt, Chapter 2: “Solute-Solvent Interactions” “Solvents and Solvent Effects in Organic Chemistry,” Edited by C. Reichardt, (WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2006) pp. 5-46.
T. Lee, and M. S. Lin, “Sublimation Point Depression of Tris(8-hydroxyquinoline)
aluminum(III) (Alq3) by Crystal Engineering,” J. Crys. Growth, 7(9), 1803-1810 (2007).
R. D. Stauffer and F. Bischoff, “Solubility determination of cholesterol polymorphs in organic solvents,” Clin. Chem., 12 (4), 206-210 (1966).
C. J. Price, “Take Some Solid Steps to Improve Crystallization,” Chem. Eng. Prog., 93(9), 34-43 (1997).
J. W. Mullin, “Crystal Habit Modification.”, Chapter 6.4 in “Crystallization,” 3rd edition, (Butterworth-Heinemann, Jordan Hill, UK, 1997) pp. 93, 248-250.
P. D. Martino, M. Beccerica, E. Joiris, G. F. Palmieri, A. Gayot, and S. Martelli, “Influence of crystal habit on the compression and densification mechanism of ibuprofen,” J. Crys. Growth, 243(2), 345-355 (2002).
D. Winn, and M. F. Doherty, “A New Technique for Predicting the Shape of Solution-Grown Organic Crystals”, AlChE J., 44(11), 2501-2514 (1998).
A. K. Tiwary, “Modification of crystal habit and its role in dosage form performance,” Drug Dev. Ind. Pharm., 27(7), 699–709 (2001).
D. Gao, and J. H. Rytting, “Use of Solution Calorimetry to Determine the Extent of Crystallinity of Drugs and Excipients,” Int. J. Pharm., 151(2), 183-192 (1997).
P. J. Haines, “Thermal Methods of Analysis – Principles, Applications and Problems,” (Blackie Academic & Professional, London, UK, 1995) p. 89.
R. Hilfiker, F. Blatter, M. V. Raumer, chapter 1: “Relevance of solid-state properties for pharmaceutical products.”, “polymorphism in pharmaceutical industry.” R. Hilfiker, (WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2006) pp. 1-19.
B. Rodriguez-Spong, C. P. Price, A. Jayasankar, A. J. Matzger, and N. Rodriguez-Hornedo, “General principles of pharmaceutical solid polymorphism: a supramolecular perspective,” Adv. Drug Del. Rev., 56(2), 241-271(2004).
T. Threlfall, “Crystallization of polymorphs: thermodynamic insight into the role of solvent,” Org. Process Res. Dev., 4(5) 384-390 (2000).
P. T. Cardew, and R. J. Davey, “The kinetics of solvent-mediated phase transformation,” Math. Phys. Sci., 398(1815), 415-428 (1985).
D. Giron, “Thermal analysis and calorimetric methods in the characterization of polymorphs and solvates,” Thermochim. Acta, 248(1), 1-59 (1995).
B. C. Hancock, P. York, and R. C. Rowe, “The use of solubility parameters in pharmaceutical dosage form design,” Int. J. Pharm., 148(1), 1-21 (1997).
A. F. M. Barton, “Handbook of solubility parameters and other cohesion parameter,” 2nd edition, (CRC Press, USA, 1991) pp. 69-149.
T. Lee, Y. H. Chen, and C. W. Zhang, “Solubility, polymorphism, crystallinity, crystal habit, and drying scheme of (R, S)-(±)-sodium ibuprofen dehydrate,” Pharm. Tech., 31(6), 72-87 (2007).
J. Kaloustian1, A. M. Pauli, P. Lechene de la Porte, H. Lafont and H. Portugal, “Thermal analysis of anhydrous and hydrate cholesterol: Application to gallstones,” J. Therm. Anal. Calorim. 71(2), 341-351 (2003).
R. M. Epand, A. D. Bain, B. G. Sayer, D. Bach, and E. Wachtel, “Properties of mixtures of cholesterol with phosphatidylcholine or with phosphatidylserine studied by 13C magic angle spinning nuclear magnetic resonance,” Bio. J., 83(4), 2053-2063 (2002).
C. R. Loomis, G. G. Shipley, and D. M. Small, “The phase behavior of hydrated cholesterol,” J. Lip. Res. 20(4) 525-535 (1979).
R. D. Stauffer and F. Biscoff, “ Observation on the interconversions of cholesterol crystal forms,” A. C. S. 148th Meeting p. 29 (1964).
N. Garti, L. Karpuj, and S. Sarig, “Correlation between crystal habit and the composition of solvated and nonsolvated cholesterol crystals,” J. Lip. Res., 22(5), 785-791 (1981).
N. G. Anderson, Practical Process Research & Development (Academic Press, New York, NY, 2000), pp. 81–111.
S. L. Morissette, O. Almarsson, M. L. Peterson, J. F. Remenar, M. J. Read, A. V. Lemmo, S. Ellis, M. J. Cima, and C. R. Gardner, “High-throughput Crystallization: Polymorphs, Salts Co-Crystals and Solvates of Pharmaceutical Solids,” Adv. Drug Del. Rev., 56(3), 275-300 (2004).
G. L. Flynn, Y. Shah, S. Parakongpan, K. H. Kwan, W. I. Higuchi, and A. F. Hofmann, “ Cholesterol solubility in organic solvents,” J. Pharm. Sci., 68(9), 1090-1097 (1979).
Z. Berkovitch-Yellin, J. Van Mil, L. Addadi, M. Idelson, M. Lahav, and L. Leiserowitz, “Crystal morphology engineering by" tailor-made" inhibitors; a new probe to fine intermolecular interactions,” J. Am. Chem. Soc., 107(11), 3111-3122 (1985).
I. Ludlam-Brown, and P. York, “The crystalline modification of succinic and by variations in crystallization conditions,” J. Phys. D Appl. Phys., 26(8B), B60-B65 (1993).
K. V. Putte, W. Skoda, and M. Petroni, “Phase transition and CH3-rotation in solid cholesterol,” Chem. Phys. Lipids, 2(4), 361-371 (1968).
R. M. Epand, D. Bach, N. Borochov, and E. Wachtel, “Cholesterol crystalline polymorphism and the solubility of cholesterol in phosphatidylserine,” Bio. J., 78(2), 866-873 (2000).
...........................................................
Chapter 4
P. J. J. A. Buijnsters, J. J. J. M. Donners, S. J. Hill, B. R. Heywood, R. J. M. Nolte, B. Zwanenburg, and N. A. J. M. Sommerdijk, “Oriented crystallization of calcium carbonate under self-organized monolayers of amide-containing phospholipids,” Langmuir, 17(12), 3623-3628 (2001).
S. Mann, B. R. Heywood, S. Rajam, and J. D. Birchall, “Controlled crystallization of CaCO3 under stearic acid monolayers,” Nature, 334(6184), 692-695 (1988).
S. Rajam, B. R. Heywood, J. B. A. Walker, and S. Mann, “Oriented crystallization of CaCO3 under compressed monolayers. Part 1. – Morphological studies of mature crystals,” J. Chem. Soc. Faraday Trans., 87(5), 727-734 (1991).
B. R. Heywood, S. Rajam, and S. Mann, “Oriented crystallization of CaCO3 under compressed Monolayers. Part 2. – Morphology, structure and growth of immature crystals,” J. Chem. Soc. Faraday Trans., 87(5), 735-743 (1991).
B. R. Heywood, and S. Mann. “Molecular construction of oriented Inorganic materials: Controlled nucleation of calcite and aragonite under compressed langmuir monolayers,” Chem. Mater., 6(3), 311-318 (1994).
A. W. Xu, M. Antonietti, S. H. Yu, and H. Colfen, “Polymer-mediated minerlization and self-similar mesoscale-organized calcium carbonate with unusual superstructures,” Adv. Mater., 20(7), 1333-1338 (2008).
C. Marteau, G. Blanc, M. A. Devaux, H. Portugal, and A. Gerolami, “Infulence of pancreatic ducts on saturation of juice with calcium carbonate in dogs,” Digestive Diseases and Sciences, 38(11), 2090-2097 (1993).
D. R. Taylor, R. S. Crowther, J. C. Cozart, P. Sharrock, J. Wu, and R. D. Soloway, “Calcium carbonate in cholesterol gallstones: polymorphism, distribution, and hypotheses about pathogenesis,” Hapatology, 22(2), 488-496 (1995).
A. W. Xu, W. F. Dong, M. Antonietti, and H. Colfen, “Polymorph switching of calcium carbonate crystals by polymer-controlled crystallization,” Adv. Funct. Mater., 18(8), 1307–1313 (2008).
M. C. Carey, “Pathogenesis of gallstones,” Am. J. Surg., 165(4), 410-419 (1993).
H. Igimi, M. C. Carey, “Cholesterol gallstone dissolution in bile: dissolution kinetics of crystalline (anhydrate and monohydrate) cholesterol with chenodeoxycholate, ursodeoxycholate, and their glycine and taurine conjugates,” J. Lipid Res., 22(2), 254-270 (1981).
F. M. Konikoff, D. S. Chung, J. M. Donovan, D. M. Small, and M. C. Carey, “Filamentous, helical, and tubular microstructures during cholesterol crystallization from bile – evidence that cholesterol does not nucleate classic monohydrate plates,” J. Clin. Invest., 90(3), 1155-1160 (1992).
D. E Cohen, M. Angelico, and M. C. Carey,” Structural alterations in lecithin-cholesterol vesicles following interactions with monomeric and micellar bile salts: physical-chemical basis for subselection of biliary lecithin species and aggregative states of biliary lipids during bile formation,” J. Lipid Res., 31(1), 55-70 (1990).
J. M. Donovan, N. Timofeyeva, and M. C. Carey, “Influence of total lipid concentration, bile salt:lecithin ratio, and cholesterol content on inter-mixed micellar/vesicular (non-lecithin- associated) bile salt concentrations in model bile,” J. Lipid Res., 32(9), 1501-1512 (1991).
D. Q. Wang, and M. C. Carey, “Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems,” J. Lipid Res., 37(3), 606-630 (1996).
R. D. Stauffer, and F. Bischoff, “Solubility determination of cholesterol polymorphs in organic solvents,” Clin. Chem., 12(4), 206-210 (1966).
H. S. Shieh, L. G. Hoard, and C. E. Nordman, “Crystal structure of anhydrous cholesterol,” Nature, 267(5608), 287-289 (1977).
B. M. Craven, “Crystal structure of cholesterol monohydrate,” Nature, 260(5553), 727-729 (1976).
C. R. Loomis, G. G. Shipley, and D. M. Small, “The phase behavior of hydrated cholesterol,” J. Lipid Res., 20(4), 525-535 (1979).
H. Y. Saad, and W. I. Higuchi, “Water solubility of cholesterol,” J. Pharm. Sci., 54(8), 1205-1206 (1965).
G. L. Flynn, Y. Shah, S. Prakongpan, K. H. Kwan, W. I. Higuchi, and A. F. Hofmann, “Cholesterol solubility in organic solvents,” J. Pharm. Sci., 68(9), 1090-1097 (1979).
N. Garti, L. Karpuj, and S. Sarig, “Correlation between crystal habit and the composition of solvated and nonsolvated cholesterol crystals,” J. Lipid Res., 22(5), 785-791 (1981).
N. R. Pattinson, “Solubilisation of cholesterol in human bile,” Feder. Eur. Biochem. Soc., 181(2), 339-342 (1985).
R. T. Holzbach, and N. Busch, “Nucleation and growth of cholesterol crystals – kinetic determinants in supersaturated native bile,” Gastroenterology Clinics of North America, 20(1), 67-84 (1991).
D. Jungst, R. Del Pozo, M. H. Dolu, S. G. Schneeweiss, and E. Frimberger, “Rapid formation of cholesterol crystals in gallbladder bile is associated with stone recurrence after laparoscopic cholecystotomy,” Hepatology, 25(3), 509-513 (1997).
C. L. Liu, and C. F. Hsu, “Cholesterol monohydrates dissolution in bile salt-lecithin solutions,” J. Chin. Chem. Soc., 47(3), 461-467 (2000).
T. Nishioka, S. Tazuma, G. Yamashita, and G. Kajiyama, “Partial replacement of bile salts causes marked changes of cholesterol crystallization in supersaturated model bile systems,” Biochem. J., 340(2), 445-451 (1999).
H. Rapaport, I. Kuzmenko, S Lafont, K. Kjaer, P. B. Howes, J. Als-Nielsen, M. Lahav, and L. Leiserowitz, “Cholesterol monohydrate nucleation in ultrathin films on water,” Biophys. J., 81(5), 2729-2736 (2001).
R. S. Abendan, and J. A. Swift, “Surface characterization of cholesterol monohydrate single crystals by chemical force microscopy,” Langmuir, 18(12), 4847-4853 (2002).
R. C. Srivastava, and R. P. S. Jakhar, “Transport through liquid membranes generated by lecithin-cholesterol mixtures,” J. Phys. Chem., 86(5), 1441-1445 (1982).
R. M. Epand, R. F. Epand, D. W. Hughes, B. G. Sayer, N. Borochov, D. Bach, and E. Wachtel, “Phosphatidylcholine structure determines cholesterol solubility and lipid polymorphism,” Chem. Phys. Lipids., 135(1), 39-53 (2005).
D. E. Cohen, M. Angelico, and M. C. Carey, “Structural alterations in lecithin-cholesterol vesicles following interactions with monomeric and micellar bile salts: physical-chemical basis for subselection of biliary lecithin species and aggregative states of biliary lipids during bile formation,” J. Lipid Res., 31(1), 55-70 (1990).
C. L. Liu, and W. I. Higuchi, “Cholesterol crystallite nucleation in supersaturated model biles from a thermodynamic standpoint,” Biochim. Biophys. Acta, Mol. Basis Dis., 1588(1), 15-25 (2002).
W. J. Claffey, and R. T. Holzbach, “Dimorphism in bile salt/lecithin mixed micelles,” Biochemistry, 20(2), 415-418 (1981).
C. L. Liu, and M. S. Weng,” Estimation of the taurocholate to lecithin molar ratio of mixed micelles in taurocholate-lecithin solutions by an interaction model and laser light-scattering measurements,” J. Chin. Chem. Soc., 50(3A), 353-360 (2003).
N. Rajagopalan, and S. Lindenbaum, “Kinetics and thermodynamics of the formation of mixed micelles of egg phosphatidylcholine and bile salts,” J. Lipid Res., 25(2), 135-147 (1984).
N. A. Mazer, G. B. Benedek, and M. C. Carey, “Quasielastic light-scattering studies of aqueous biliary lipid systems. mixed micelle formation in bile salt-lecithin solution,” Biochemistry, 19(4), 601-615 (1980).
D. Meyuhas, A. Bor, I. Pinchuk, A. Kaplun, Y. Talmon, M. M. Kozlov, and D. Lichtenberg, “Effect of ionic strength on the self-assembly in mixtures of phosphatidylcholine and sodium cholate,” J. Colloid Inter. Sci., 188(2), 351-362 (1997).
D. D. Lasic, “Kinetic and thermodynamic effects on the structure and formation of phosphatidylcholine vesicles,” Hepatology, 13(5), 1010-1012 (1991).
P. K. Vinson, Y. Talmon, and A. Walter, “Vesicle-micelle transition of phosphatidylcholine and octyl glucoside elucidated by cryo-transmission electron microscopy,” Biophys. J., 56(4), 669-681 (1989).
Y. Li, J. F. Holzwarth, and C. Bohne, “Aggregation dynamics of sodium taurodeoxycholate and sodium deoxycholate,” Langmuir, 16(4), 2038-2041 (2000).
E. Bottari, A. A. D’Archivio, M. R. Festa, L. Galantini, and E. Giglio, “Structure composition of sodium taurocholate micellar aggregates,” Langmuir, 15(8), 2996-2998 (1999).
R. H. Dowling, “Review: pathogenesis of gallstones,” Aliment. Pharmacol. Ther., 14(2), 39-47 (2002).
S. M. Meyerhoffer, and L. B. McGown, “Critical micelle concentration behavior of sodium taurocholate in water,” Langmuir, 6(1), 187-191 (1990).
S. Kuroki, B. I. Cohen, M. C. Carey, and E. H. Mosbach, “Rapid computation with the personal computer of the percent cholesterol saturation of bile samples,” J. Lipid Res., 27(4), 442-446 (1986).
R. C. Srivastava, and R. P. S. Jakhar, “Transport through liquid membranes generated by lecithin-cholesterol mixtures,” J. Phys. Chem., 86(8), 1441-1445 (1982).
D. L. Gantz, D. Q.-H. Wang, M. C. Carey, and D. M. Small, “Cryoelectron microscopy of a nucleating model bile in vitreous ice: formation of primordial vesicles,” Biophys. J., 76(3), 1436-1451 (1999).
M. C. Carey, “Critical tables for calculating the cholesterol saturation of native bile,” J. Lipid Res., 19(8), 945-955 (1978).
D. Q-H. Wang, and M. C. Carey, “Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles: identical pathways to corresponding model biles with three predominating sequences,” J. Lipid Res., 37(12), 2539-2549 (1996).
A. J. Xie, Y. F. Yang, C. L. Yao, Y. H. Shen, Y. M. Yang, X. R. Yu, C. Y. Zhang, and X. M. Zhu, “Influence of calcium binding proteins on the precipitation of calcium carbonate: A kinetic and morphologic study,” Cryst. Res. Technol., 41(12), 1214-1218 (2006).
P. Portincasa, A. Moschetta, K. J. van Erpecum, G. Calamita, A. Margari, G. P. van Berge-Henegouwen, and G. Palasciano, “Pathways of cholesterol crystallization in model bile and native bile,” Digestive and Liver Disease., 35(2), 118-126 (2003).
A. Bauer-Brandl, “Polymorphic transitions of cimetidine during manufacture of solid dosage forms,” Int. J. Pharm., 140(2), 195-206 (1996).
Z. Halpern, M. A. Dudley, M. P. Lynn, J. M. Nader, A. C. Breuer, and R. T. Holzbach, “Vesicle aggregation in model systems of supersaturated bile: relation to crystal nucleation and lipid composition of the vesicular phase,” J. Lipid Res., 27(3), 295-306 (1986)
D. Papahadjopoulos, W. J. Vail, C. Newton, S. Nir, K. Jacobson, G. Poste, and R. Lazo, “Studies on membrane fusion. III. The role of calcium-induced phase changes,” Biochim. Biophys. Acta., 465(3), 579-98 (1977).
D. Meyuhas, A. Bor, I. Pinchuk, A. Kaplun, Y. Talmon, M. M. Kozlov, and D. Lichtenberg, “Effect of ionic strength on the self-assembly in mixtures of phosphatidylcholine and sodium cholate,” J. Colloid Inter. Sci., 188(2), 351-362 (1997).
A. Vecht, and T. G. Ireland, “The role of vaterite and aragonite in the formation of pseudo-biogenic carbonate structures: Implications for martian exobiology,” Geochim. Cosmochim. Acta., 64(15), 2719-2725 (2000).
D. O. Shah, and J. H. Schulman, “Binding of metal ions to monolayers of lecithins, plasmalogen, cardiolipin, and dicetyl phosphate,” J. Lipid Res., 6(3), 341-349 (1965)
H. Tong, P. Wan, W. Ma, G. Zhong, L. Cao, and J. Hu, “Yolk spherocrystal: The structure, composition and liquid crystal template,” J. Struct. Biol., 163(1), 1-9 (2008).
H. Grasdalen, E. Göran, J. Westman, and A. Ehrenberg, “Surface potential effects on metal ion binding to phosphatidylcholine membranes 31P NMR study of lanthanide and calcium ion binding to egg-yolk lecithin vesicles,” Biochim. Biophys. Acta., 469(2), 151-156 (1977).
A. W. Xu, M. Antonietti, H. Colfen, and Y. P. Fang, “Uniform hexagonal plates of vaterite CaCO3 mesocrystals formed by biomimetic mineralization,” Adv. Funct. Mater., 16(7), 903-908 (2006).
S. Uematsu, T. Uchida, A. Kinoshita, F. Kimura, and Y. Akahori, “Relation between micellar structure of model bile and activity of esterase,” Biochim. Biophys. Acta., 1258(2), 122-134 (1995).
H. S. Kaufman, T. H. Magnuson, H. A. Pitt, P. Frasca, and K. D. Lillemoe, “The distribution of calcium slat precipitates in core, periphery and shell of cholesterol, black pigment and brown pigment gallstones,” Hepatology, 19(5), 1124-1132 (1994).
T. Ogino, T. Suzuki, and K. Sawada, “The formation and transformation mechanism of calcium carbonate in water,” Geochim. Cosmochim. Acta., 51(10), 2757-2767 (1987).
S. Gouin, and X. X. Zhu, “Fluorescence and NMR studies of the effect of a bile acid dimer on the micellization of bile salts,” Langmuir, 14(15), 4025-4029 (1998).
E. W. Moore, “The role of calcium in the pathogenesis of gallstones: Ca2+ electrode studies of model bile salt solutions and other biologic systems,” Hepatology, 4(5), 228S-243S (1984).
N. Ikeda, F. Marumo, M. Shirataka, and T. Sato, “A model of overall regulation of body fluids,” Ann. Biomed. Eng., 7(2), 135-166 (1979).
D. M. Henderson, “Effects of surfactants on Faraday-wave dynamics,” J. Fluid Mech., 365, 89-107 (1998).
T. G. Gabig, and B. M. Babior, “The killing of pathogens by phagocytes,” Annu. Rev. Med., 32(1), 313-326 (1981).
H. Hauser, M. C. Phillips, B. A. Levine, and R. J. P. Williams, “Ion-binding to phospholipids: Interaction of calcium and lanthanide ions with phosphatidylcholine (Lecithin),” Eur. J. Biochem., 58 (1), 133-144 (1975).
|